eedq has been researched along with Anochlesia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creese, I; Hamblin, MW | 1 |
| Crocker, AD; Double, KL; Lee, CY | 1 |
| Fuxe, K; Ogren, SO; Rosén, L | 1 |
| Corda, MG; Giorgi, O; Loi, R; Pibiri, MG | 1 |
| Chen, JF; Qin, ZH; Weiss, B | 1 |
| Dal Toso, R; Giorgi, O; Pibiri, MG; Ragatzu, G | 1 |
| Agnati, LF; Cimino, M; Farabegoli, C; Fuxe, K; Merlo Pich, E | 1 |
| Albers, LJ; Creese, I; Hess, EJ; Le, H | 1 |
8 other study(ies) available for eedq and Anochlesia
| Article | Year |
|---|---|
Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Quinolines; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Time Factors | 1983 |
Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
Topics: Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Catalepsy; Dopamine Antagonists; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra | 1995 |
The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
Topics: Animals; Binding, Competitive; Brain; Catalepsy; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Limbic System; Male; Motor Activity; Quinolines; Raclopride; Rats; Receptors, Dopamine; Remoxipride; Salicylamides; Substantia Nigra | 1994 |
Chronic treatment with SCH 23390 increases the production rate of dopamine D1 receptors in the nigro-striatal system of the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Benzazepines; Catalepsy; Corpus Striatum; Half-Life; Male; Membranes; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Substantia Nigra; Up-Regulation | 1993 |
Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
Topics: Animals; Base Sequence; Behavior, Animal; Catalepsy; Corpus Striatum; Dopamine Antagonists; Gene Expression; Male; Mice; Mice, Inbred Strains; Molecular Sequence Data; Oligonucleotide Probes; Oxidopamine; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Stereotyped Behavior | 1994 |
Age-related changes in the turnover rates of D1-dopamine receptors in the retina and in distinct areas of the rat brain.
Topics: Adrenergic alpha-Antagonists; Aging; Animals; Benzazepines; Brain; Catalepsy; Corpus Striatum; Kinetics; Male; Motor Activity; Nucleus Accumbens; Organ Specificity; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Retina; Substantia Nigra; Time Factors | 1992 |
Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours.
Topics: Adrenergic alpha-Antagonists; Age Factors; Animals; Catalepsy; Corpus Striatum; Male; Motor Activity; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Uridine | 1988 |
Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Behavior, Animal; Benzazepines; Catalepsy; Corpus Striatum; Cyclic AMP; Guanosine Triphosphate; Male; Motor Activity; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin | 1986 |